For Southeastern United States FamiliesEarly Alzheimer's Evaluation in Cuba in Southeastern United States
The Southeastern United States — including Florida, Mississippi, Louisiana, South Carolina, and neighboring states — is home to over 1.1 million Americans living with Alzheimer's. This region has some of the highest Alzheimer's prevalence rates in the nation, driven by large senior populations, significant African American communities (who face disproportionately high dementia risk), and high diabetes rates that compound cognitive decline. Miami, Tampa, and Fort Lauderdale offer the most convenient direct charter flights to Havana, while Atlanta, Charlotte, and New Orleans provide connecting flight options.
1.1M
Southeastern United States residents with Alzheimer's
6
states in region
1–5 hours (varies by departure city)
to Havana
Direct
flights available
Why Early Evaluation Matters Across Southeastern United States
Early evaluation is one of the most powerful tools in Alzheimer's care. The Alzheimer's Association emphasizes that early and accurate diagnosis can help patients explore treatment options, maintain independence longer, participate in clinical trials, and plan for the future while they still can. In the United States, however, comprehensive early evaluation is often limited by insurance coverage and appointment availability.
Cuba's early evaluation program is designed for patients with mild cognitive impairment (MCI) or early-stage Alzheimer's disease. The evaluation includes detailed neuropsychological testing to distinguish normal aging from MCI and early Alzheimer's, brain MRI to assess hippocampal atrophy and other early markers, blood work to rule out reversible causes of cognitive decline, and a comprehensive multidisciplinary team assessment.
Following the evaluation, the medical team provides a personalized treatment plan that may include NeuroEPO research (available for mild cognitive impairment and mild Alzheimer's), intensive cognitive rehabilitation (most effective when started early, when neuroplasticity is greatest), pharmacological management, and caregiver education. Early intervention offers the best opportunity to slow cognitive decline and maintain function — though no treatment currently cures Alzheimer's, and individual outcomes vary.
No treatment currently cures Alzheimer's disease. Cuba's program aims to slow cognitive decline, maintain function, and improve quality of life. NeuroEPO is investigational and not FDA-approved. Treatment suitability is determined after individual medical evaluation. Individual outcomes vary.
State-by-State Guides
Early Alzheimer's Evaluation in Cuba by State in Southeastern United States
Select your state for detailed information about early alzheimer's evaluation in cuba options, travel logistics, and state-specific resources.
City-Level Guides
Early Alzheimer's Evaluation in Cuba by City in Southeastern United States
Travel from Southeastern United States
Getting to Havana from Southeastern United States
Major Departure Airports
- Miami (MIA)
- Tampa (TPA)
- Fort Lauderdale (FLL)
- Atlanta (ATL)
- Charlotte (CLT)
- New Orleans (MSY)
Travel time: 1–5 hours (varies by departure city)
Travel Authorization
- • U.S. citizens can travel to Cuba under approved categories
- • SMC Salud provides letter of medical necessity
- • Treatment confirmation documentation included
- • Airport reception and ground transport in Havana
- • English-speaking coordinators throughout your stay
Frequently Asked Questions
Questions from Southeastern United States Families
Yes. U.S. citizens can travel to Cuba under approved categories. SMC Salud provides all necessary documentation, including the letter of medical necessity and treatment confirmation, to support travel authorization. Our team guides you through the entire process to ensure compliance with all regulations.
Ready to Explore Early Alzheimer's Evaluation in Cuba in Cuba?
Submit your medical records for a complimentary review. Families across Southeastern United States receive a personalized treatment proposal within 5–10 business days.